Development and exploratory analysis of software to detect look-alike, sound-alike medicine names
Embargo Lift Date
MetadataShow full item record
Background: ‘Look-alike, sound-alike’ (LASA) medicines may be confused by prescribers, pharmacists, nurses and patients, with serious consequences for patient safety. The current research aimed to develop and trial software to proactively identify LASA medicines by computing medicine name similarity scores. Methods: Literature review identified open-source software from the United States Food and Drug Administration for screening of proposed medicine names. We adapted and refined this software to compute similarity scores (0.0000–1.0000) for all possible pairs of medicines registered in Australia. Two-fold exploratory analysis compared: • Computed similarity scores vs manually-calculated similarity scores that had used a different algorithm and underpinned development of Australia's 2011 Tall Man Lettering List (‘the 2011 List’) • Computed risk category vs expert-consensus risk category that underpinned the 2011 List. Results: Screening of the Australian medicines register identified 7,750 medicine pairs with at least moderate (arbitrarily ≥0.6600) name similarity, including many oncology, immunomodulating and neuromuscular-blocking medicines. Computed similarity scores and resulting risk categories demonstrated a modest correlation with the manually-calculated similarity scores (r = 0.324, p < 0.002, 95 % CI 0.119–0.529). However, agreement between the resulting risk categories was not significant (Cohen's kappa = −0.162, standard error = 0.063). Conclusions: The software (LASA v2) has potential to identify pairs of confusable medicines. It is recommended to supplement incident reports in risk-management programs, and to facilitate pre-screening of medicine names prior to brand/trade name approval and inclusion of medicines in formularies.
Showing items related by title, author, creator and subject.
Emmerton, Lynne; Rizk, M. (2012)‘Look-alike, sound-alike’ medicines are associated with dispensing errors. This commentary aims to fuel discussion surrounding how drug name nomenclature and similar packaging between medicines can lead to selection errors, ...
Evidence-to-practice gaps in the management of community-dwelling Australian patients with ischaemic heart diseaseSchmid, O.; Stafford, Leanne; Bereznicki, L. (2015)© 2015 John Wiley & Sons Ltd.Summary What is known and objective Ischaemic heart disease (IHD) is a major cause of death in developed countries. Patients with IHD are at greater risk of subsequent myocardial infarction ...
Inoue, Madoka (2012)This thesis examines infant feeding practices, including knowledge and attitudes towards breastfeeding, factors that influence the duration of breastfeeding, and breastfeeding outcomes in relation to postpartum women’s ...